Browsing by Autor "Guy Van den Mooter"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item type: Item , Enhancing photostability and minimizing volatility of a promising drug candidate(Elsevier BV, 2024) Vivian Ruz Sanjuan; Clóvis Augusto Ribeiro; Jorge Enrique Rodríguez Chanfrau; Amalia María Calvo Alonso; Eryvaldo Sócrates Tabosa do Egito; Guy Van den Mooter; Anselmo Gomes de OliveiraItem type: Item , Photodegradation of the antibacterial, antifungal and antiprotozoal drug candidate 2-(2-nitrovinyl) furan (G-0) in solid inclusion complexes with β-cyclodextrin derivatives: Characterization by NMR spectroscopy and in silico toxicity screening(Elsevier BV, 2025) Vivian Ruz Sanjuan; Antônio G. Ferreira; Enoel Hernández-Barreto; Guy Van den Mooter; Mirtha Mayra González Bedia; Eryvaldo Sócrates Tabosa do Egito; Anselmo Gomes de OliveiraThis work aimed to evaluate the effect of inclusion complex (IC) formation between the drug candidate 2-(2-nitrovinyl) furan (G-0) and hydroxypropyl β-cyclodextrin (HP-β-CD) or sulfobutylether β-cyclodextrin (SBE-β-CD) on the drug's photostability under light exposure. Freeze-dried cyclodextrin inclusion complexes (ICs) and their corresponding physical mixtures were subjected to standardized forced irradiation and light exposure conditions according to ICH guidelines. Kinetic analysis suggested potential alterations in photodegradation pathways. The HPLC chromatographic profile of the ICs exhibited a distinct impurity pattern compared to the physical mixtures, while the profiles of the two ICs were similar. The main photodegradation product (PD1) was identified with a retention time of 5.4 min and a maximum absorption wavelength (λ<sub>max</sub>) of 330 nm. PD1 was isolated using High-Performance Liquid Chromatography with diode array detection (HPLC-DAD) and further characterized through Nuclear Magnetic Resonance (NMR) spectroscopy. Combining 1D (<sup>1</sup>H NMR, <sup>13</sup>C {<sup>1</sup>H}) and 2D (COSY, HSQC and HMBC) NMR measurements revealed the presence of two substances in equilibrium, identified as (2Z,4Z)-5-nitropenta-2,4-dienoic acid (NPDA) and its corresponding salt. The hazard classification of NPDA was assessed following ICH M7 guidelines using QSAR and expert rule-based toxicity screening methods, providing insights into its potential risk profile.